A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial

Journal:

Nature Medicine

Published:

2025-07-10

DOI:

10.1038/s41591-025-03792-7

Affiliations:

12

Authors:

28

Go to article

Institutions	Authors	Share
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	19.000000 19.000000	0.68
Biokin Pharma, China	3.000000	0.11
The First Affiliated Hospital of Xinxiang Medical University, China	1.000000	0.04
Jinan Central Hospital, China	1.000000	0.04
The First Affiliated Hospital of Henan University of Science and Technology, China	1.000000	0.04
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	1.000000	0.04
The General Hospital, TMU, China	1.000000	0.04
Zhejiang Cancer Hospital (ZJCH), China	1.000000	0.04

Interested in Oncology and Carcinogenesis?